IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation - PubMed (original) (raw)
. 1999 Nov 1;163(9):5049-55.
Affiliations
- PMID: 10528210
IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation
L A Joosten et al. J Immunol. 1999.
Abstract
Anti-TNF-alpha treatment of rheumatoid arthritis patients markedly suppresses inflammatory disease activity, but so far no tissue-protective effects have been reported. In contrast, blockade of IL-1 in rheumatoid arthritis patients, by an IL-1 receptor antagonist, was only moderately effective in suppressing inflammatory symptoms but appeared to reduce the rate of progression of joint destruction. We therefore used an established collagen II murine arthritis model (collagen-induced arthritis(CIA)) to study effects on joint structures of neutralization of either TNF-alpha or IL-1. Both soluble TNF binding protein and anti-IL-1 treatment ameliorated disease activity when applied shortly after onset of CIA. Serum analysis revealed that early anti-TNF-alpha treatment of CIA did not decrease the process in the cartilage, as indicated by the elevated COMP levels. In contrast, anti-IL-1 treatment of established CIA normalized COMP levels, apparently alleviating the process in the tissue. Histology of knee and ankle joints corroborated the finding and showed that cartilage and joint destruction was significantly decreased after anti-IL-1 treatment but was hardly affected by anti-TNF-alpha treatment. Radiographic analysis of knee and ankle joints revealed that bone erosions were prevented by anti-IL-1 treatment, whereas the anti-TNF-alpha-treated animals exhibited changes comparable to the controls. In line with these findings, metalloproteinase activity, visualized by VDIPEN production, was almost absent throughout the cartilage layers in anti-IL-1-treated animals, whereas massive VDIPEN appearance was found in control and sTNFbp-treated mice. These results indicate that blocking of IL-1 is a cartilage- and bone-protective therapy in destructive arthritis, whereas the TNF-alpha antagonist has little effect on tissue destruction.
Similar articles
- Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB. Joosten LA, et al. Arthritis Res. 1999;1(1):81-91. doi: 10.1186/ar14. Epub 1999 Oct 26. Arthritis Res. 1999. PMID: 11056663 Free PMC article. - Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
Lubberts E, Joosten LA, van Den Bersselaar L, Helsen MM, Bakker AC, van Meurs JB, Graham FL, Richards CD, van Den Berg WB. Lubberts E, et al. J Immunol. 1999 Oct 15;163(8):4546-56. J Immunol. 1999. PMID: 10510398 - Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB. Lubberts E, et al. Arthritis Rheum. 2004 Feb;50(2):650-9. doi: 10.1002/art.20001. Arthritis Rheum. 2004. PMID: 14872510 - Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
Abramson SB, Amin A. Abramson SB, et al. Rheumatology (Oxford). 2002 Sep;41(9):972-80. doi: 10.1093/rheumatology/41.9.972. Rheumatology (Oxford). 2002. PMID: 12209029 Review. - Joint inflammation and cartilage destruction may occur uncoupled.
van den Berg WB. van den Berg WB. Springer Semin Immunopathol. 1998;20(1-2):149-64. doi: 10.1007/BF00832004. Springer Semin Immunopathol. 1998. PMID: 9836374 Review.
Cited by
- Control of autoimmune inflammation by celastrol, a natural triterpenoid.
Venkatesha SH, Dudics S, Astry B, Moudgil KD. Venkatesha SH, et al. Pathog Dis. 2016 Aug;74(6):ftw059. doi: 10.1093/femspd/ftw059. Epub 2016 Jul 11. Pathog Dis. 2016. PMID: 27405485 Free PMC article. Review. - Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent.
Adriaansen J, Khoury M, de Cortie CJ, Fallaux FJ, Bigey P, Scherman D, Gould DJ, Chernajovsky Y, Apparailly F, Jorgensen C, Vervoordeldonk MJ, Tak PP. Adriaansen J, et al. Ann Rheum Dis. 2007 Sep;66(9):1143-50. doi: 10.1136/ard.2006.064519. Epub 2007 Mar 15. Ann Rheum Dis. 2007. PMID: 17363402 Free PMC article. - Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart.
Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Gatewood SJ, Njoku DB, Rose NR. Fairweather D, et al. Am J Pathol. 2004 Dec;165(6):1883-94. doi: 10.1016/s0002-9440(10)63241-5. Am J Pathol. 2004. PMID: 15579433 Free PMC article. - SPA0355, a thiourea analogue, inhibits inflammatory responses and joint destruction in fibroblast-like synoviocytes and mice with collagen-induced arthritis.
Lee YR, Hwang JK, Lee HS, Cheon YJ, Ryu JH, Lee SI, Kwak HB, Lee SM, Kim JS, Park JW, Jeon R, Park BH. Lee YR, et al. Br J Pharmacol. 2011 Sep;164(2b):794-806. doi: 10.1111/j.1476-5381.2011.01441.x. Br J Pharmacol. 2011. PMID: 21501144 Free PMC article. - Semaphorin 3A Inhibits Inflammation in Chondrocytes under Excessive Mechanical Stress.
Sumi C, Hirose N, Yanoshita M, Takano M, Nishiyama S, Okamoto Y, Asakawa Y, Tanimoto K. Sumi C, et al. Mediators Inflamm. 2018 Apr 8;2018:5703651. doi: 10.1155/2018/5703651. eCollection 2018. Mediators Inflamm. 2018. PMID: 29849491 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous